This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rapp, J. P. Articles by Sustarsic, D. L. Search for Related Content PubMed PubMed Citation Articles by Rapp, J. P. Articles by Sustarsic, D. L.

Hypertension, Vol 4, 20-26, Copyright © 1982 by American Heart Association

ARTICLES

Anomalous response of urinary kallikrein to deoxycorticosterone in Dahl salt-sensitive rats

JP Rapp, RP McPartland and DL Sustarsic

Previous evidence shows that salt-sensitive (S) rats have a net increase in plasma mineralocorticoid activity due to 18-hydroxy-11- deoxycorticosterone and decreased urinary kallikrein excretion compared to salt-resistant (R) rats. Since mineralocorticoids stimulate urinary kallikrein excretion, these results are inconsistent. This inconsistency was explained by the fact that, while R rats responded normally to treatment with deoxycorticosterone (DOC) by an increase in urinary kallikrein excretion, S rats showed no change in urinary kallikrein even when treated with 10 mg of DOC/day for 24 days. S and R rats responded identically to DOC with changes muscle electrolytes and relative hypertrophy of the renal distal tubule. Other measures of chronic mineralocorticoid response in S rats beside kallikrein were, therefore, intact. It was found that S rats were capable of responding to Na deficient diet with an increase in urinary kallikrein comparable to R rats. It was argued, therefore, that mineralocorticoid receptor mechanisms and distal-tubular cell responsiveness are intact in S rats. Mild glomerular and tubular scarring was found in S rats and the severity of renal lesions was increased by DOC treatment in S rats. These lesions correlated well with blood pressure and proteinuria. No such lesions were present in control or DOC treated R rats. It was suggested that failure of urinary kallikrein to respond to DOC in S rats may be a secondary phenomenon resulting from renal damage.

This article has been cited by other articles:

				N. E. Taylor, P. Glocka, M. Liang, and A. W. Cowley Jr NADPH Oxidase in the Renal Medulla Causes Oxidative Stress and Contributes to Salt-Sensitive Hypertension in Dahl S Rats Hypertension, April 1, 2006; 47(4): 692 - 698. [Abstract] [Full Text] [PDF]

				Y. Wang and D. H. Wang A Novel Mechanism Contributing to Development of Dahl Salt-Sensitive Hypertension: Role of the Transient Receptor Potential Vanilloid Type 1 Hypertension, March 1, 2006; 47(3): 609 - 614. [Abstract] [Full Text] [PDF]

				A. W. Cowley Jr, R. J. Roman, M. L. Kaldunski, P. Dumas, J. G. Dickhout, A. S. Greene, and H. J. Jacob Brown Norway Chromosome 13 Confers Protection From High Salt to Consomic Dahl S Rat Hypertension, February 1, 2001; 37(2): 456 - 461. [Abstract] [Full Text] [PDF]

				T. Kurtz and R. Morris Jr Dietary chloride as a determinant of "sodium-dependent" hypertension Science, December 9, 1983; 222(4628): 1139 - 1141. [Abstract] [PDF]